Search

Your search keyword '"Panitumumab -- Forecasts and trends"' showing total 25 results

Search Constraints

Start Over You searched for: Descriptor "Panitumumab -- Forecasts and trends" Remove constraint Descriptor: "Panitumumab -- Forecasts and trends"
25 results on '"Panitumumab -- Forecasts and trends"'

Search Results

1. Epidermal Growth Factor Receptor (EGFR) Inhibitors Market to grow by USD 6.75 billion from 2024 to 2028, North America to account for 40% of market growth

2. Epidermal Growth Factor Receptor (EGFR) Inhibitors Market to grow by USD 6.75 billion from 2024 to 2028, North America to account for 40% of market growth- Technavio

3. Global Cancer Monoclonal Antibodies Market Report 2023: Players Include Amgen, Bristol Myers Squibb, Eli Lilly and Company, F. Hoffmann-La Roche and Genmab

4. Colorectal Cancer Drugs Global Market Report 2023: Sector to Reach $16.22 Billion in 2027 at a CAGR of 3.3%

5. Colorectal Cancer Drugs Global Market Report 2023

6. Cancer Monoclonal Antibodies Market Report 2022: Rising Preference for Personalized Medicines Provides Boost to Sector

7. Cancer Monoclonal Antibodies Market Report 2022: Widespread Adoption of Cost-Efficient Biosimilar Monoclonal Antibodies Driving Growth

8. Cancer Monoclonal Antibodies Market Report 2022: Widespread Adoption of Cost-Efficient Biosimilar Monoclonal Antibodies Driving Growth - ResearchAndMarkets.com

9. Global Colorectal Cancer Drugs Industry Analysis, 2022-2026, Featuring Merck & Co, Roche, Sanofi, Amgen, and Pfizer Among Others

10. Global $16.4B Colorectal Cancer Drugs Market Outlook, 2026 - Diagnosed Incident Cases Expected to Increase by 27.3%, to 672,400 Cases by 2037

11. Global Colorectal Cancer Drugs Industry Analysis, 2022-2026, Featuring Merck & Co, Roche, Sanofi, Amgen, and Pfizer Among Others - ResearchAndMarkets.com

12. Global $16.4B Colorectal Cancer Drugs Market Outlook, 2026 - Diagnosed Incident Cases Expected to Increase by 27.3%, to 672,400 Cases by 2037

13. Global Colorectal Cancer Drugs Industry Analysis, 2022-2026, Featuring Merck & Co, Roche, Sanofi, Amgen, and Pfizer Among Others

14. Global Cancer Monoclonal Antibodies Market Report 2022-2031: Major Players are BMS, Eli Lilly and Co, F. Hoffmann-La Roche, Genmab, GSK, Johnson & Johnson, Novartis, Merck and Spectrum

15. Global Cancer Monoclonal Antibodies Market Report 2022-2031: Major Players are BMS, Eli Lilly and Co, F. Hoffmann-La Roche, Genmab, GSK, Johnson & Johnson, Novartis, Merck and Spectrum - ResearchAndMarkets.com

16. Global Cancer Monoclonal Antibodies Market Report 2022-2031: Major Players are BMS, Eli Lilly and Co, F. Hoffmann-La Roche, Genmab, GSK, Johnson & Johnson, Novartis, Merck and Spectrum

17. Colorectal Cancer Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030 Following a 2.2% Decrease in 2021

18. Colorectal Cancer Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030 Following a 2.2% Decrease in 2021 - ResearchAndMarkets.com

19. Colorectal Cancer Drugs Global Market Report 2021: COVID-19 Impact and Recovery to 2030 Following a 2.2% Decrease in 2021

20. Laryngeal Cancer Therapeutics Market to Grow by USD 635.07 Million during 2021-2025|Amgen Inc. and AstraZeneca Plc Emerge as Key Contributors to Growth |Technavio

21. Global Cancer Monoclonal Antibodies Market Report 2020-2030: COVID-19 Growth and Changes for the $45.4 Billion Industry - ResearchAndMarkets.com

22. Global Cancer Monoclonal Antibodies Market Report 2020-2030: COVID-19 Growth and Changes for the $45.4 Billion Industry

23. Cancer Monoclonal Antibodies Global Market Report 2020-30: COVID-19 Growth and Change

24. Cancer Monoclonal Antibodies Global Market Report 2020-30: COVID-19 Growth and Change

25. Global Cancer Monoclonal Antibodies Markets, 2020-2025

Catalog

Books, media, physical & digital resources